139 related articles for article (PubMed ID: 7926521)
1. Role of urokinase, its receptor, and serpins in colorectal carcinoma.
Jessup JM
Gastroenterology; 1994 Nov; 107(5):1555-9. PubMed ID: 7926521
[No Abstract] [Full Text] [Related]
2. Urokinase-dependent proteolysis in cultured colon cancer is directed by its receptor.
Hollas W; Boyd D
Semin Thromb Hemost; 1991 Jul; 17(3):225-30. PubMed ID: 1665585
[No Abstract] [Full Text] [Related]
3. Proteases and cancer invasion: from belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998.
Blasi F; Stoppelli MP
Biochim Biophys Acta; 1999 Jan; 1423(1):R35-44. PubMed ID: 9989212
[No Abstract] [Full Text] [Related]
4. Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1.
Bruckner A; Filderman AE; Kirchheimer JC; Binder BR; Remold HG
Cancer Res; 1992 Jun; 52(11):3043-7. PubMed ID: 1375533
[TBL] [Abstract][Full Text] [Related]
5. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.
Abe J; Urano T; Konno H; Erhan Y; Tanaka T; Nishino N; Takada A; Nakamura S
Cancer; 1999 Dec; 86(12):2602-11. PubMed ID: 10594855
[TBL] [Abstract][Full Text] [Related]
6. Influence of urokinase on cell proliferation and invasion.
Binder BR
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):717-20. PubMed ID: 1966799
[TBL] [Abstract][Full Text] [Related]
7. Evolving role of uPA/uPAR system in human cancers.
Dass K; Ahmad A; Azmi AS; Sarkar SH; Sarkar FH
Cancer Treat Rev; 2008 Apr; 34(2):122-36. PubMed ID: 18162327
[TBL] [Abstract][Full Text] [Related]
8. Non-enzymatic activities of proteases: from scepticism to reality.
Del Rosso M; Fibbi G; Schmitt M
Biol Chem; 2002 Jan; 383(1):1-4. PubMed ID: 11928804
[No Abstract] [Full Text] [Related]
9. Function of receptor-bound urokinase.
Kirchheimer JC; Binder BR
Semin Thromb Hemost; 1991 Jul; 17(3):246-50. PubMed ID: 1665586
[No Abstract] [Full Text] [Related]
10. The urokinase receptor and regulation of cell surface plasminogen activation.
Blasi F; Behrendt N; Cubellis MV; Ellis V; Lund LR; Masucci MT; Møller LB; Olson DP; Pedersen N; Ploug M
Cell Differ Dev; 1990 Dec; 32(3):247-53. PubMed ID: 1965953
[No Abstract] [Full Text] [Related]
11. Effect of antisense inhibition of Urokinase receptor on malignancy.
Ossowski L
Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():101-12. PubMed ID: 8815000
[No Abstract] [Full Text] [Related]
12. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis.
Friess H; Cantero D; Graber H; Tang WH; Guo X; Kashiwagi M; Zimmermann A; Gold L; Korc M; Büchler MW
Gastroenterology; 1997 Sep; 113(3):904-13. PubMed ID: 9287983
[TBL] [Abstract][Full Text] [Related]
13. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
Félez J; Rueda F
Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
[No Abstract] [Full Text] [Related]
15. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype.
Swiercz R; Wolfe JD; Zaher A; Jankun J
Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
Fazioli F; Blasi F
Trends Pharmacol Sci; 1994 Jan; 15(1):25-9. PubMed ID: 8140655
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of tumour metastasis.
Meyer T; Hart IR
Eur J Cancer; 1998 Feb; 34(2):214-21. PubMed ID: 9741324
[No Abstract] [Full Text] [Related]
18. Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.
Paul R; Winkler F; Bayerlein I; Popp B; Pfister HW; Koedel U
J Infect Dis; 2005 Mar; 191(5):776-82. PubMed ID: 15688295
[TBL] [Abstract][Full Text] [Related]
19. The biologic role of components of the plasminogen-plasmin system.
Kwaan HC
Prog Cardiovasc Dis; 1992; 34(5):309-16. PubMed ID: 1531879
[No Abstract] [Full Text] [Related]
20. Mechanisms of signaling through urokinase receptor and the cellular response.
Koshelnick Y; Ehart M; Stockinger H; Binder BR
Thromb Haemost; 1999 Aug; 82(2):305-11. PubMed ID: 10605718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
